
Isoray ISR
Geschäftsbericht 2025
hinzugefügt 16.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
73.8 M |
Marktkapitalisierung |
$ 108 M |
EBITDA (LTM) |
$ -41.2 M |
P/E (LTM) |
- |
P/S (LTM) |
13.42 |
EPS (LTM) |
-1.03 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 125.38 | 1.74 % | $ 4.01 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.22 | -1.74 % | $ 195 M | Nasdaq Capital Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Microbot Medical
MBOT
|
$ 2.37 | -2.67 % | $ 109 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 70.03 | -0.72 % | $ 4.14 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 80.84 | 1.13 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.42 | 4.2 % | $ 25.3 M | Nasdaq Capital Market | ||
|
Haemonetics Corporation
HAE
|
$ 62.0 | 2.51 % | $ 3.12 B | NYSE,SPB | ||
|
The Cooper Companies
COO
|
$ 70.22 | -1.95 % | $ 14 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 221.33 | -1.56 % | $ 21.8 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Harvard Bioscience
HBIO
|
$ 5.16 | 5.09 % | $ 229 M | Nasdaq Global Market | ||
|
Teleflex Incorporated
TFX
|
$ 125.0 | -0.17 % | $ 5.58 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 6.43 | -1.82 % | $ 54.5 K | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 120.28 | -0.2 % | $ 5.83 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 1.94 % | $ 20.7 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 178.38 | -0.01 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 67.93 | -0.64 % | $ 220 M | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 124.27 | -2.8 % | $ 3.06 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.27 | -8.85 % | $ 22.2 M | NYSE American | ||
|
InfuSystem Holdings
INFU
|
$ 10.15 | 1.55 % | $ 210 M | NYSE American | ||
|
Envista Holdings Corporation
NVST
|
$ 27.11 | -0.99 % | $ 4.55 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 50.83 | -3.68 % | $ 167 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 469.65 | 0.52 % | $ 168 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 114.64 | -2.34 % | $ 2.6 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.17 | -0.45 % | $ 2.43 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 20.9 | 3.11 % | $ 963 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 17.62 | 0.17 % | $ 9.04 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 228.97 | -0.75 % | $ 33.4 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.6 | 0.68 % | $ 1.41 B | Nasdaq Global Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 19.56 | -2.81 % | $ 1.32 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 2.0 | -1.72 % | $ 182 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 24.56 | 0.53 % | $ 1.22 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 266.95 | -0.37 % | $ 19.3 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.45 | -0.19 % | $ 427 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.34 | -0.25 % | $ 44.7 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.95 | 2.43 % | $ 30.6 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
- | - | $ 237 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 132.46 | 1.09 % | $ 7.38 M | Nasdaq Global Select Market,SPB |